In melanoma, HCC, and CRC, copy number gains were identified at the 6p21 locus (chr6: 30,950,307–33,085,850), which harbors G9a, leading to G9a overexpression [27,52,57]. Here, EHMT2 is linked to hepatocellular carcinoma.